We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MTX:XETRMTU Aero Engines AG Analysis

Data as of 2026-06-21 - not real-time

$78.67

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Minerals Technologies Inc. (MTX) is trading in a bullish technical environment – the price sits above both the 20‑day and 50‑day moving averages, the MACD histogram is positive and volume is on an upward trend, while the RSI hovers around the mid‑50s, indicating balanced momentum. Fundamentally, the company delivers solid top‑line growth of roughly 11% YoY, healthy operating margins near 12%, and a very modest dividend payout of about 9% of earnings, which supports dividend sustainability.
However, the DCF‑derived fair value (~$37) is well below the current market price (~$79), suggesting the stock is overvalued on a valuation basis. The balance sheet shows a manageable debt‑to‑equity ratio below 55% and ample cash generation, but the 30‑day volatility of nearly 28% and a beta under 1 point to moderate market sensitivity. Overall, the upside potential is limited by valuation stretch, yet the company’s diversified product portfolio and global footprint provide a defensive cushion for longer horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Positive MACD crossover with expanding histogram
  • Price firmly above 20‑day SMA and near recent support
  • Increasing trading volume indicating growing interest

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Consistent revenue growth and improving margins
  • Low dividend payout ratio supporting cash retention
  • Debt level manageable relative to cash and earnings

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Diversified global product mix across specialty chemicals and engineered solutions
  • Sustainable dividend with modest payout
  • Valuation premium relative to intrinsic DCF estimate

Key Metrics & Analysis

Financial Health

Revenue Growth11.20%
Profit Margin7.60%
P/E Ratio15.5
ROE9.79%
ROA5.30%
Debt/Equity54.85
P/B Ratio1.4
Op. Cash Flow$230.2M
Free Cash Flow$85.3M

Technical Analysis

TrendBullish
RSI57.2
Support$73.87
Resistance$79.85
MA 20$76.99
MA 50$75.78
MA 200$66.93
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair Value$37.17
Target Price$94.25
Upside/Downside19.80%
GradeOvervalued
TypeBlend
Dividend Yield0.61%

Risk Assessment

Beta0.86
Volatility27.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.